Recipharm, a contract development and manufacturing organization (CDMO), and Exela Pharma Sciences, a US-based client-centric CDMO, have entered an exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States.   This collaboration will provide Recipharm with access to Exela’s manufacturing facility located in Lenoir, North Carolina. The facility, accredited by the FDA (CDER and CBER), has a proven track record of delivering “light speed” project...